Blog Posts

Elisabetta Bonzano: Post-hoc TAILORx analysis at SABCS24

Elisabetta Bonzano/X

Dec 15, 2024, 14:54

Elisabetta Bonzano: Post-hoc TAILORx analysis at SABCS24

Elisabetta Bonzano, Radiation Oncologist at IRCCS San Matteo Polyclinic Foundation, shared a post on X:

“Post-hoc TAILORx analysis: Impact of Anthracyclines in High Genomic Risk Node-Negative HR+/HER2- Breast Cancer by Nan Chen.”

More posts featuring Elisabetta Bonzano.

Anthracyclines Breast Cancer cancer Elisabetta Bonzano OncoDaily Oncology SABCS24 TAILORx

Patrick Soon-Shiong: 30 Years and $3B Toward a Universal Cancer Fighter

Vinay Prasad Rejoins FDA Days After Exit

New Paper Alert: Safety and Outcomes of T-DXd Retreatment After Grade 1 ILD Recovery

FDA Accepts NDA for Vepdegestrant in ESR1-Mutant ER+/HER2- Advanced Breast Cancer

Hubert Caron Retires from Roche-Genentech

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023

Facebook

Youtube

Voices

Aug 15, 2025, 21:03

Drew Moghanaki: Cautionary Lessons from Dr. Mammarappallil on Percutaneous MWA for Lung Tumors

Voices

Aug 15, 2025, 21:01

Oliver Bogler: The NIH Review Process Doesn’t Have to Be a Mystery - Learn How to Navigate Study Section

Voices

Aug 15, 2025, 20:42

Heloisa Soares: Huntsman Cancer Institute Theranostics Program is Expanding

Insight

Aug 15, 2025, 20:14

Guilherme Harada: Honored to Have Contributed to This Study

Insight

Aug 15, 2025, 19:54

Rahul Banerjee: Faster, More Accurate Detection of Multiple Myeloma Progression

Voices

Aug 15, 2025, 19:27

Michael Chuong: Exciting Developments in RT for Pancreatic Cancer

Voices

Aug 15, 2025, 16:15

Theodoros Teknos: Case Comprehensive Cancer Center Awarded $25.5M NCI Cancer Center Support Grant

Science

Aug 15, 2025, 16:10

Saheli Sadanand: Excited to Share a New Cancer Vaccine Study in Nature Medicine

Voices

Aug 15, 2025, 16:00

Amy C Moore Highlights Persistent Challenges in Lung Cancer Survival and Research

Voices

Aug 15, 2025, 15:57

David Heredia Highlighted New Research on Membrane Targets in RET+ NSCLC

Voices

Aug 15, 2025, 15:57

Stephen Liu: Proud to Co-chair The 2026 Texas Lung Cancer Conference with Dr. Tina Cascone

Voices

Aug 15, 2025, 15:57

Minhua Chu: KRAS G12D Inhibitor GFH375 Delivers Strong Responses in NSCLC